Pioneering repository aims to raise visibility and awareness about people with mental illnesses

Pfiz­er ter­mi­nat­ed one of two late-stage tri­als for a sick­le cell treat­ment can­di­date from its $5.4 bil­lion ac­qui­si­tion of Glob­al Blood Ther­a­peu­tics in 2022. The

Open the door to Boehringer In­gel­heim’s apart­ment ex­hib­it to­day in New York City, and you’ll see vast dis­ar­ray — cloth­ing and shoes piled on the

For the three months ended 30 June 2024, Amgen’s GAAP EPS decreased by 46% to $1.38 from $2.57 in Q2 2023. Credit: Amgen Inc. Amgen